Fingerprint
Dive into the research topics of 'A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: Enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically